Hawaii 2025 Regular Session

Hawaii Senate Bill SB1509

Introduced

1/23/25

Refer

1/27/25

Refer

2/13/25

Report Pass

2/28/25

Engrossed

3/4/25

Refer

3/6/25

Report Pass

3/14/25

Refer

3/14/25

Caption

Relating To Prescription Drugs.

Latest SB1509 Activity

Companion Bills

No companion bills found.

Previously Filed As

HI HB951

Relating To Prescription Drugs.

HI HF213

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drug benefits, and including applicability provisions.

HI SSB1207

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs.

HI HF405

A bill for an act relating to insurance coverage for prescription insulin drugs.

HI SF209

A bill for an act relating to insurance coverage for prescription insulin drugs.

HI HF658

A bill for an act relating to insurance coverage for prescription insulin drugs.

HI SF197

A bill for an act relating to insurance coverage for prescription drugs used in the treatment of metastatic cancer and associated conditions.

HI SF264

A bill for an act relating to prescription drug affordability, including the creation of a prescription drug affordability board.

Similar Bills

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

AZ HB2291

Opioids; containers; labeling; requirements; repeal

TX HB2859

Relating to prescriber and dispenser reporting and access to patient prescription information under the Texas Controlled Substances Act.

NJ A1853

Requires all prescriptions be transmitted electronically, subject to certain exceptions.